Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Neurotherapeutics
Erschienen in: Neurotherapeutics 2/2016

01.04.2016 | Review

Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?

verfasst von: Thomas Wichmann, Mahlon R. DeLong

Erschienen in: Neurotherapeutics | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Deep brain stimulation (DBS) is highly effective for both hypo- and hyperkinetic movement disorders of basal ganglia origin. The clinical use of DBS is, in part, empiric, based on the experience with prior surgical ablative therapies for these disorders, and, in part, driven by scientific discoveries made decades ago. In this review, we consider anatomical and functional concepts of the basal ganglia relevant to our understanding of DBS mechanisms, as well as our current understanding of the pathophysiology of two of the most commonly DBS-treated conditions, Parkinson’s disease and dystonia. Finally, we discuss the proposed mechanism(s) of action of DBS in restoring function in patients with movement disorders. The signs and symptoms of the various disorders appear to result from signature disordered activity in the basal ganglia output, which disrupts the activity in thalamocortical and brainstem networks. The available evidence suggests that the effects of DBS are strongly dependent on targeting sensorimotor portions of specific nodes of the basal ganglia-thalamocortical motor circuit, that is, the subthalamic nucleus and the internal segment of the globus pallidus. There is little evidence to suggest that DBS in patients with movement disorders restores normal basal ganglia functions (e.g., their role in movement or reinforcement learning). Instead, it appears that high-frequency DBS replaces the abnormal basal ganglia output with a more tolerable pattern, which helps to restore the functionality of downstream networks.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Guridi J, Lozano AM. A brief history of pallidotomy. Neurosurgery 1997;41:1169-80.
2.
Wichmann T, DeLong MR, Guridi J, Obeso JA. Milestones in research on the pathophysiology of Parkinson's disease. Mov Disord 2011;26:1032-1041.
3.
Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
4.
Hariz MI, Hariz GM. Therapeutic stimulation versus ablation. Handb Clin Neurol 2013;116:63-71.
5.
Benabid AL, Pollak P, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403-406.
6.
Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-1438.
7.
Hariz M, Blomstedt P, Zrinzo L. Future of brain stimulation: new targets, new indications, new technology. Mov Disord 2013;28:1784-1792.
8.
Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381.
9.
Middleton FA, Strick PL. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Rev 2000;31:236-250.
10.
Hoover JE, Strick PL. Multiple output channels in the basal ganglia. Science 1993;259:819-821.
11.
Hartmann-von Monakow K, Akert K, Kunzle H. Projections of the precentral motor cortex and other cortical areas of the frontal lobe to the subthalamic nucleus in the monkey. Exp Brain Res 1978;33:395-403.
12.
Nambu A, Takada M, Inase M, Tokuno H. Dual somatotopical representations in the primate subthalamic nucleus: evidence for ordered but reversed body-map transformations from the primary motor cortex and the supplementary motor area. J Neurosci 1996;16:2671-2683.
13.
Deniau JM, Chevalier G. Disinhibition as a basic process in the expression of striatal functions. II. The striato-nigral influence on thalamocortical cells of the ventromedial thalamic nucleus. Brain Res 1985;334:227-233.
14.
Chevalier G, Vacher S, Deniau JM, Desban M. Disinhibition as a basic process in the expression of striatal functions. I. The striato-nigral influence on tecto-spinal/tecto-diencephalic neurons. Brain Res 1985;334:215-226.
15.
Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
16.
DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285.
17.
Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. Progress in Neurobiology 1996;50:381-425.
18.
Nambu A. Seven problems on the basal ganglia. Curr Opin Neurobiol 2008;18:595-604.
19.
Nambu A, Tokuno H, Takada M. Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway. Neurosci Res 2002;43:111-117.
20.
Georgopoulos AP, DeLong MR, Crutcher MD. Relations between parameters of step-tracking movements and single cell discharge in the globus pallidus and subthalamic nucleus of the behaving monkey. J Neurosci 1983;3:1586-1598.
21.
Mazzoni P, Hristova A, Krakauer JW. Why don't we move faster? Parkinson's disease, movement vigor, and implicit motivation. J Neurosci 2007;27:7105-7116.
22.
Hwang EJ. The basal ganglia, the ideal machinery for the cost-benefit analysis of action plans. Front Neural Circuits 2013;7:121.
23.
Grillner S, Robertson B, Stephenson-Jones M. The evolutionary origin of the vertebrate basal ganglia and its role in action selection. J Physiol 2013;591:5425-5431.
24.
Mink JW, Thach WT. Basal ganglia intrinsic circuits and their role in behavior. Curr Opin Neurobiol 1993;3:950-957.
25.
Bateup HS, Santini E, Shen W, et al. Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors. Proc Natl Acad Sci U S A 2010;107:14845-14850.
26.
Kravitz AV, Freeze BS, Parker PR, et al. (eds). Optogenetic dissection of basal ganglia circuit function in normal and parkinsonian mice. IBAGS X; 2010; Long Branch, NJ, USA.
27.
Freeze BS, Kravitz AV, Hammack N, Berke JD, Kreitzer AC. Control of basal ganglia output by direct and indirect pathway projection neurons. J Neurosci 2013;33:18531-18539.
28.
Verbruggen F, Logan GD. Models of response inhibition in the stop-signal and stop-change paradigms. Neurosci Biobehav Rev 2009;33:647-661.
29.
Liddle EB, Scerif G, Hollis CP, et al. Looking before you leap: a theory of motivated control of action. Cognition 2009;112:141-158.
30.
Band GP, van Boxtel GJ. Inhibitory motor control in stop paradigms: review and reinterpretation of neural mechanisms. Acta Psychol (Amst) 1999;101:179-211.
31.
Aron AR, Poldrack RA. Cortical and subcortical contributions to Stop signal response inhibition: role of the subthalamic nucleus. J Neurosci 2006;26:2424-2433.
32.
Chambers CD, Garavan H, Bellgrove MA. Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. Neurosci Biobehav Rev 2009;33:631-646.
33.
Kuhn AA, Williams D, Kupsch A, et al. Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance. Brain 2004;127:735-746.
34.
Aron AR, Durston S, Eagle DM, Logan GD, Stinear CM, Stuphorn V. Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition. J Neurosci 2007;27:11860-11864.
35.
Eagle DM, Baunez C, Hutcheson DM, Lehmann O, Shah AP, Robbins TW. Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb Cortex 2008;18:178-188.
36.
Isoda M, Hikosaka O. Role for subthalamic nucleus neurons in switching from automatic to controlled eye movement. J Neurosci 2008;28:7209-7218.
37.
Eagle DM, Baunez C. Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neurosci Biobehav Rev 2010;34:50-72.
38.
Baunez C, Humby T, Eagle DM, Ryan LJ, Dunnett SB, Robbins TW. Effects of STN lesions on simple vs choice reaction time tasks in the rat: preserved motor readiness, but impaired response selection. Eur J Neurosci 2001;13:1609-1616.
39.
Baunez C, Nieoullon A, Amalric M. In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit. J Neurosci 1995;15:6531-6541.
40.
Baunez C, Robbins TW. Bilateral lesions of the subthalamic nucleus induce multiple deficits in an attentional task in rats. Eur J Neurosci 1997;9:2086-2099.
41.
Hikosaka O, Isoda M. Brain mechanisms for switching from automatic to controlled eye movements. Prog Brain Res 2008;171:375-382.
42.
Mitchell SJ, Richardson RT, Baker FH, DeLong MR. The primate globus pallidus: Neuronal activity related to direction of movement. Exp Brain Res 1987;68:491-505.
43.
Turner RS, Anderson ME. Pallidal discharge related to the kinematics of reaching movements in two dimensions. J Neurophys 1997;77:1051-1074.
44.
Wichmann T, Bergman H, DeLong MR. The primate subthalamic nucleus. I. Functional properties in intact animals. J Neurophys 1994;72:494-506.
45.
Jaeger D, Gilman S, Aldridge JW. Neuronal activity in the striatum and pallidum of primates related to the execution of externally cued reaching movements. Brain Res 1995;694:111-127.
46.
Turner RS, DeLong MR. Corticostriatal activity in primary motor cortex of the macaque. J Neurosci 2000;20:7096-7108.
47.
Bauswein E, Fromm C, Preuss A. Corticostriatal cells in comparison with pyramidal tract neurons: contrasting properties in the behaving monkey. Brain Res 1989;493:198-203.
48.
DeLong MR, Alexander GE, Mitchell SJ, Richardson RT. The contribution of basal ganglia to limb control. Prog Brain Res 1986;64:161-174.
49.
Turner RS, Desmurget M. Basal ganglia contributions to motor control: a vigorous tutor. Curr Opin Neurobiol 2010;20:704-716.
50.
Wichmann T, DeLong MR. Deep-brain stimulation for neurologic and psychiatric disorders. In: Steiner H, Tseng KY (eds). Handbook of basal ganglia structure and function. handbook of behavioral neuroscience. London: Academic Press (Elsevier); 2010. pp. 659-681.
51.
Obeso JA, Jahanshahi M, Alvarez L, et al. What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson's disease. Exp Neurol 2009;220:283-292.
52.
Mink JW, Thach WT. Basal ganglia motor control. III. Pallidal ablation: normal reaction time, muscle cocontraction, and slow movement. J Neurophys 1991;65:330-351.
53.
van Donkelaar P, Stein JF, Passingham RE, Miall RC. Temporary inactivation in the primate motor thalamus during visually triggered and internally generated limb movements. J Neurophys 2000;83:2780-2790.
54.
Canavan AG, Nixon PD, Passingham RE. Motor learning in monkeys (Macaca fascicularis) with lesions in motor thalamus. Exp Brain Res 1989;77:113-126.
55.
Nandi D, Jenkinson N, Stein J, Aziz T. The pedunculopontine nucleus in Parkinson's disease: primate studies. Br J Neurosurg 2008;22(Suppl. 1):S4-S8.
56.
Galvan A, Smith Y. The primate thalamostriatal systems: Anatomical organization, functional roles and possible involvement in Parkinson's disease. Basal Ganglia 2011;1:179-189.
57.
Fisher SD, Reynolds JN. The intralaminar thalamus-an expressway linking visual stimuli to circuits determining agency and action selection. Front Behav Neurosci 2014;8:115.
58.
Lanciego JL, Rodriguez-Oroz MC, Blesa FJ, et al. Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys. Mov Disord 2008;23:708-715.
59.
Stefani A, Peppe A, Pierantozzi M, et al. Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex. Brain Res Bull 2009;78:113-118.
60.
Cebrian C, Parent A, Prensa L. Patterns of axonal branching of neurons of the substantia nigra pars reticulata and pars lateralis in the rat. J Comp Neurol 2005;492:349-369.
61.
Beckstead RM. Long collateral branches of substantia nigra pars reticulata axons to thalamus, superior colliculus and reticular formation in monkey and cat. Multiple retrograde neuronal labeling with fluorescent dyes. Neurosci 1983;10:767-779.
62.
Kha HT, Finkelstein DI, Pow DV, Lawrence AJ, Horne MK. Study of projections from the entopeduncular nucleus to the thalamus of the rat. J Comp Neurol 2000;426:366-377.
63.
Spann BM, Grofova I. Nigropedunculopontine projection in the rat: an anterograde tracing study with phaseolus vulgaris-leucoagglutinin (PHA-L). J Comp Neurol 1991;311:375-388.
64.
Grofova I, Zhou M. Nigral innervation of cholinergic and glutamatergic cells in the rat mesopontine tegmentum: light and electron microscopic anterograde tracing and immunohistochemical studies. J Comp Neurol 1998;395:359-379.
65.
Steininger TL, Rye DB, Wainer BH. Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies. J Comp Neurol 1992;321:515-543.
66.
Parent A, Mackey A, Smith Y, Boucher R. The output organization of the substantia nigra in primate as revealed by a retrograde double labeling method. Brain Res Bull 1983;10:529-537.
67.
Harnois C, Filion M. Pallidofugal projections to thalamus and midbrain: a quantitative antidromic activation study in monkeys and cats. Exp Brain Res 1982;47:277-285.
68.
Parent A, DeBellefeuille L. Organization of efferent projections from the internal segment of globus pallidus in primate as revealed by fluorescence retrograde labeling method. Brain Res 1982;245:201-213.
69.
Moon-Edley S, Graybiel AM. The afferent and efferent connections of the feline nucleus tegmenti pedunculopontinus, pars compacta. J Comp Neurol 1983;217:187-215.
70.
DeVito JL, Anderson ME. An autoradiographic study of efferent connections of the globus pallidus in Macaca mulatta. Exp Brain Res 1982;46:107-117.
71.
Shink E, Sidibe M, Smith Y. Efferent connections of the internal globus pallidus in the squirrel monkey: II. Topography and synaptic organization of pallidal efferents to the pedunculopontine nucleus. J Comp Neurol 1997;382:348-363.
72.
Parent M, Levesque M, Parent A. The pallidofugal projection system in primates: evidence for neurons branching ipsilaterally and contralaterally to the thalamus and brainstem. J Chem Neuroanat 1999;16:153-165.
73.
Parent M, Levesque M, Parent A. Two types of projection neurons in the internal pallidum of primates: single-axon tracing and three-dimensional reconstruction. J Comp Neurol 2001;439:162-175.
74.
Mena-Segovia J, Bolam JP, Magill PJ. Pedunculopontine nucleus and basal ganglia: distant relatives or part of the same family? Trends Neurosci 2004;27:585-588.
75.
Smith Y, Hazrati LN, Parent A. Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J Comp Neurol 1990;294:306-323.
76.
Parent A, Smith Y. Organization of efferent projections of the subthalamic nucleus in the squirrel monkey as revealed by retrograde labeling methods. Brain Res 1987;436:296-310.
77.
Jones BE, Beaudet A. Distribution of acetylcholine and catecholamine neurons in the cat brainstem: a choline acetyltransferase and tyrosine hydroxylase immunohistochemical study. J Comp Neurol 1987;261:15-32.
78.
Lavoie B, Parent A. Pedunculopontine nucleus in the squirrel monkey: distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons. J Comp Neurol 1994;344:190-209.
79.
Rye DB, Saper CB, Lee HJ, Wainer BH. Pedunculopontine tegmental nucleus of the rat: cytoarchitecture, cytochemistry, and some extrapyramidal connections of the mesopontine tegmentum. J Comp Neurol 1987;259:483-528.
80.
Inglis WL, Winn P. The pedunculopontine tegmental nucleus: where the striatum meets the reticular formation. Prog Neurobiol 1995;47:1-29.
81.
Garcia-Rill E. The pedunculopontine nucleus. Prog Neurobiol 1991;36:363-389.
82.
Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 2000;123:1767-1783.
83.
Jackson A, Crossman AR. Nucleus tegmenti pedunculopontinus: Efferent connections with special reference to the basal ganglia, studied in the rat by anterograde and retrograde transport of horseradish peroxidase. Neurosci 1983;10:725-765.
84.
Sherman D, Fuller PM, Marcus J, et al. Anatomical location of the mesencephalic locomotor region and its possible role in locomotion, posture, cataplexy, and parkinsonism. Front Neurol 2015;6:140.
85.
Lavoie B, Parent A. Pedunculopontine nucleus in the squirrel monkey: projections to the basal ganglia as revealed by anterograde tract-tracing methods. J Comp Neurol 1994;344:210-231.
86.
Mena-Segovia J, Winn P, Bolam JP. Cholinergic modulation of midbrain dopaminergic systems. Brain Res Rev 2008;58:265-271.
87.
Rye DB, Lee HJ, Saper CB, Wainer BH. Medullary and spinal efferents of the pedunculopontine tegmental nucleus and adjacent mesopontine tegmentum in the rat. J Comp Neurol 1988;269:315-341.
88.
Vincent SR. The ascending reticular activating system—from aminergic neurons to nitric oxide. J Chem Neuroanat 2000;18:23-30.
89.
Grofova I, Keane S. Descending brainstem projections of the pedunculopontine tegmental nucleus in the rat. Anat Embryol (Berl) 1991;184:275-290.
90.
Garcia-Rill E, Simon C, Smith K, Kezunovic N, Hyde J. The pedunculopontine tegmental nucleus: from basic neuroscience to neurosurgical applications: arousal from slices to humans: implications for DBS. J Neural Transm 2011;118:1397-1407.
91.
Muthusamy KA, Aravamuthan BR, Kringelbach ML, et al. Connectivity of the human pedunculopontine nucleus region and diffusion tensor imaging in surgical targeting. J Neurosurg 2007;107:814-820.
92.
Aravamuthan BR, Muthusamy KA, Stein JF, Aziz TZ, Johansen-Berg H. Topography of cortical and subcortical connections of the human pedunculopontine and subthalamic nuclei. Neuroimage 2007;37:694-705.
93.
Benarroch EE. Pedunculopontine nucleus: functional organization and clinical implications. Neurology 2013;80:1148-1155.
94.
Bostan AC, Dum RP, Strick PL. The basal ganglia communicate with the cerebellum. Proc Natl Acad Sci U S A 2010;107:8452-8456.
95.
Hallett M. Tremor: pathophysiology. Parkinsonism Relat Disord 2014;20(Suppl. 1):S118-S122.
96.
Prudente CN, Hess EJ, Jinnah HA. Dystonia as a network disorder: what is the role of the cerebellum? Neurosci 2014;260:23-35.
97.
Niethammer M, Carbon M, Argyelan M, Eidelberg D. Hereditary dystonia as a neurodevelopmental circuit disorder: Evidence from neuroimaging. Neurobiol Dis 2011;42:202-209.
98.
Neychev VK, Fan X, Mitev VI, Hess EJ, Jinnah HA. The basal ganglia and cerebellum interact in the expression of dystonic movement. Brain 2008;131:2499-2509.
99.
Gerfen CR. Dopamine receptor function in the basal ganglia. Clin Neuropharmacol 1995;18:S162-S177.
100.
Murer MG, Tseng KY, Kasanetz F, Belluscio M, Riquelme LA. Brain oscillations, medium spiny neurons, and dopamine. Cell Mol Neurobiol 2002;22:611-632.
101.
Tseng KY, Kasanetz F, Kargieman L, Riquelme LA, Murer MG. Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. J Neurosci 2001;21:6430-6439.
102.
Wilson CJ, Kawaguchi Y. The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J Neurosci 1996;16:2397-2410.
103.
Rommelfanger KS, Wichmann T. Extrastriatal dopaminergic circuits of the basal ganglia. Front Neuroanat 2010;4:139.
104.
Yin HH, Mulcare SP, Hilario MR, et al. Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat Neurosci 2009;12:333-341.
105.
Graybiel AM. Habits, rituals, and the evaluative brain. Annu Rev Neurosci 2008;31:359-387.
106.
Graybiel AM. The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol 2005;15:638-644.
107.
Pennartz CM, Berke JD, Graybiel AM, et al. Corticostriatal interactions during learning, memory processing, and decision making. J Neurosci 2009;29:12831-12838.
108.
Kubota Y, Liu J, Hu D, et al. Stable encoding of task structure coexists with flexible coding of task events in sensorimotor striatum. J Neurophysiol 2009;102:2142-2160.
109.
Miyachi S, Hikosaka O, Lu X. Differential activation of monkey striatal neurons in the early and late stages of procedural learning. Exp Brain Res 2002;146:122-126.
110.
Nakahara H, Doya K, Hikosaka O. Parallel cortico-basal ganglia mechanisms for acquisition and execution of visuomotor sequences - a computational approach. J Cogn Neurosci 2001;13:626-647.
111.
Rand MK, Hikosaka O, Miyachi S, et al. Characteristics of sequential movements during early learning period in monkeys. Exp Brain Res 2000;131:293-304.
112.
Hikosaka O, Nakahara H, Rand MK, et al. Parallel neural networks for learning sequential procedures. Trends Neurosci 1999;22:464-471.
113.
Hikosaka O, Miyashita K, Miyachi S, Sakai K, Lu X. Differential roles of the frontal cortex, basal ganglia, and cerebellum in visuomotor sequence learning. Neurobiol Learn Mem 1998;70:137-149.
114.
Miyachi S, Hikosaka O, Miyashita K, Karadi Z, Rand MK. Differential roles of monkey striatum in learning of sequential hand movement. Exp Brain Res 1997;115:1-5.
115.
Restivo L, Frankland PW. Shifting to automatic. Front Integr Neurosci 2010;4:1.
116.
Ashby FG, Turner BO, Horvitz JC. Cortical and basal ganglia contributions to habit learning and automaticity. Trends Cogn Sci 2010;14:208-215.
117.
Steele CJ, Penhune VB. Specific increases within global decreases: a functional magnetic resonance imaging investigation of five days of motor sequence learning. J Neurosci 2010;30:8332-8341.
118.
Swett BA, Contreras-Vidal JL, Birn R, Braun A. Neural substrates of graphomotor sequence learning: a combined FMRI and kinematic study. J Neurophysiol 2010;103:3366-3377.
119.
Fiorillo CD, Tobler PN, Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science 2003;299:1898-1902.
120.
Waelti P, Dickinson A, Schultz W. Dopamine responses comply with basic assumptions of formal learning theory. Nature 2001;412:43-48.
121.
Schultz W, Tremblay L, Hollerman JR. Reward processing in primate orbitofrontal cortex and basal ganglia. Cerebr Cortex 2000;10:272-284.
122.
Schultz W, Dickinson A. Neuronal coding of prediction errors. Annu Rev Neurosci 2000;23:473-500.
123.
Hollerman JR, Schultz W. Dopamine neurons report an error in the temporal prediction of reward during learning. Nat Neurosci 1998;1:304-309.
124.
Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science 1997;275:1593-1599.
125.
Mirenowicz J, Schultz W. Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli. Nature 1996;379:449-451.
126.
Matsumoto M, Hikosaka O. Representation of negative motivational value in the primate lateral habenula. Nat Neurosci 2009;12:77-84.
127.
Wickens J. Toward an anatomy of disappointment: reward-related signals from the globus pallidus. Neuron 2008;60:530-531.
128.
Matsumoto M, Hikosaka O. Negative motivational control of saccadic eye movement by the lateral habenula. Prog Brain Res 2008;171:399-402.
129.
Hikosaka O, Sesack SR, Lecourtier L, Shepard PD. Habenula: crossroad between the basal ganglia and the limbic system. J Neurosci 2008;28:11825-11829.
130.
Matsumoto M, Hikosaka O. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 2007;447:1111-1115.
131.
Ji H, Shepard PD. Lateral habenula stimulation inhibits rat midbrain dopamine neurons through a GABA(A) receptor-mediated mechanism. J Neurosci 2007;27:6923-6930.
132.
Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
133.
Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci U S A 1987;84:5976-5980.
134.
Karachi C, Grabli D, Bernard FA, et al. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest 2010;120:2745-2754.
135.
Rinne JO, Ma SY, Lee MS, Collan Y, Roytta M. Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients. Parkinsonism Relat Disord 2008;14:553-557.
136.
Pienaar IS, Elson JL, Racca C, Nelson G, Turnbull DM, Morris CM. Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease. Am J Pathol 2013;183:1826-1840.
137.
Alam M, Schwabe K, Krauss JK. The pedunculopontine nucleus area: critical evaluation of interspecies differences relevant for its use as a target for deep brain stimulation. Brain 2011;134:11-23.
138.
Garcia-Rill E, Hyde J, Kezunovic N, Urbano FJ, Petersen E. The physiology of the pedunculopontine nucleus: implications for deep brain stimulation. J Neural Transm 2015;122:225-235.
139.
Muller ML, Bohnen NI. Cholinergic dysfunction in Parkinson's disease. Curr Neurol Neurosci Rep 2013;13:377.
140.
Crossman AR, Mitchell IJ, Sambrook MA. Regional brain uptake of 2-deoxyglucose in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the macaque monkey. Neuropharmacol 1985;24:587-591.
141.
Schwartzman RJ, Alexander GM. Changes in the local cerebral metabolic rate for glucose in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) primate model of Parkinson's disease. Brain Res 1985;358:137-143.
142.
Filion M, Tremblay L, Bedard PJ. Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys. Brain Res 1988;444:165-176.
143.
Miller WC, DeLong MR. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: Carpenter MB, Jayaraman A (eds) The basal ganglia II. New York: Plenum Press; 1987. pp. 415-427.
144.
Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophys 1994;72:507-520.
145.
Wichmann T, Bergman H, Starr PA, Subramanian T, Watts RL, DeLong MR. Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp Brain Res 1999;125:397-409.
146.
Galvan A, Devergnas A, Wichmann T. Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state. Front Neuroanat 2015;9:5.
147.
Wichmann T, Soares J. Neuronal firing before and after burst discharges in the monkey basal ganglia is predictably patterned in the normal state and altered in parkinsonism. J Neurophys 2006;95:2120-2133.
148.
Zirh TA, Lenz FA, Reich SG, Dougherty PM. Patterns of bursting occurring in thalamic cells during parkinsonian tremor. Neurosci 1998;83:107-121.
149.
Urbain N, Rentero N, Gervasoni D, Renaud B, Chouvet G. The switch of subthalamic neurons from an irregular to a bursting pattern does not solely depend on their GABAergic inputs in the anesthetic-free rat. J Neurosci 2002;22:8665-8675.
150.
Chan V, Starr PA, Turner RS. Bursts and oscillations as independent properties of neural activity in the parkinsonian globus pallidus internus. Neurobiol Dis 2011;41:2-10.
151.
Gatev P, Darbin O, Wichmann T. Oscillations in the basal ganglia under normal conditions and in movement disorders. Mov Disord 2006;21:1566-1577.
152.
Hammond C, Bergman H, Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 2007;30:357-364.
153.
Pasquereau B, Turner RS. Primary motor cortex of the parkinsonian monkey: differential effects on the spontaneous activity of pyramidal tract-type neurons. Cereb Cortex 2011;21:1362-1378.
154.
Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:142-151.
155.
Wichmann T, DeLong MR. Basal ganglia discharge abnormalities in Parkinson's disease. J Neural Transm Suppl 200;70:21-25.
156.
Miguelez C, Morin S, Martinez A, et al. Altered pallido-pallidal synaptic transmission leads to aberrant firing of globus pallidus neurons in a rat model of Parkinson's disease. J Physiol 2012;590:5861-5875.
157.
Chu HY, Atherton JF, Wokosin D, Surmeier DJ, Bevan MD. Heterosynaptic regulation of external globus pallidus inputs to the subthalamic nucleus by the motor cortex. Neuron 2015;85:364-376.
158.
Fan KY, Baufreton J, Surmeier DJ, Chan CS, Bevan MD. Proliferation of external globus pallidus-subthalamic nucleus synapses following degeneration of midbrain dopamine neurons. J Neurosci 2012;32:13718-13728.
159.
Terman D, Rubin JE, Yew AC, Wilson CJ. Activity patterns in a model for the subthalamopallidal network of the basal ganglia. J Neurosci 2002;22:2963-2976.
160.
Bevan MD, Magill PJ, Terman D, Bolam JP, Wilson CJ. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 2002;25:525-531.
161.
Lourens MA, Meijer HG, Contarino MF, et al. Functional neuronal activity and connectivity within the subthalamic nucleus in Parkinson's disease. Clin Neurophysiol 2013;124:967-981.
162.
Brown P, Williams D. Basal ganglia local field potential activity: character and functional significance in the human. Clin Neurophysiol 2005;116:2510-2519.
163.
Feng H, Zhuang P, Hallett M, Zhang Y, Li J, Li Y. Characteristics of subthalamic oscillatory activity in parkinsonian akinetic-rigid type and mixed type. Int J Neurosci 2015:1-10.
164.
Dupre KB, Cruz AV, McCoy AJ, et al. Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease. Neurobiol Dis 2016;86:1-15.
165.
de Hemptinne C, Ryapolova-Webb ES, Air EL, et al. Exaggerated phase-amplitude coupling in the primary motor cortex in Parkinson disease. Proc Natl Acad Sci U S A 2013;110:4780-4785.
166.
Ingham CA, Hood SH, Taggart P, Arbuthnott GW. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci 1998;18:4732-4743.
167.
Day M, Wang Z, Ding J, et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006;9:251-259.
168.
Deutch AY. Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson's disease. J Neural Transm Suppl 2006:67-70.
169.
Raju DV, Ahern TH, Shah DJ, et al. Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism. Eur J Neurosci 2008;27:1647-1658.
170.
Villalba RM, Smith Y. Striatal spine plasticity in Parkinson's disease. Front Neuroanat 2010;4:133.
171.
Villalba RM, Smith Y. Differential structural plasticity of corticostriatal and thalamostriatal axo-spinous synapses in MPTP-treated Parkinsonian monkeys. J Comp Neurol 2011;519:989-1005.
172.
Villalba RM, Smith Y. Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine? Neurosci 2013;251:2-20.
173.
Mathai A, Ma Y, Pare JF, Villalba RM, Wichmann T, Smith Y. Reduced cortical innervation of the subthalamic nucleus in MPTP-treated parkinsonian monkeys. Brain 2015;138:946-962.
174.
Chu H-Y, Bevan MD. Long-term potentiation of external globus pallidus-subthalamic nucleus synapses following activation of motor cortical inputs. Soc Neurosci Ann Meeting Abstr 2013;270:13.
175.
Hallett M. Parkinson's disease tremor: pathophysiology. Parkinsonism Relat Disord 2012;18(Suppl. 1):S85-S86.
176.
Wu T, Hallett M. The cerebellum in Parkinson's disease. Brain 2013;136:696-709.
177.
Mure H, Hirano S, Tang CC, et al. Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effects. Neuroimage 2011;54:1244-1253.
178.
Klein JC, Barbe MT, Seifried C, et al. The tremor network targeted by successful VIM deep brain stimulation in humans. Neurology 2012;78:787-795.
179.
Hariz MI, Krack P, Alesch F, et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry 2008;79:694-699.
180.
Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28:863-873.
181.
Ozelius LJ, Hewett J, Kramer P, et al. Fine localization of the torsion dystonia gene (DYT1) on human chromosome 9q34: YAC map and linkage disequilibrium. Genome Res 1997;7:483-494.
182.
Quartarone A, Hallett M. Emerging concepts in the physiological basis of dystonia. Mov Disord 2013;28:958-967.
183.
Wichmann T. Commentary: Dopaminergic dysfunction in DYT1 dystonia. Exp Neurol 2008;212:242-246.
184.
Augood SJ, Hollingsworth Z, Albers DS, et al. Dopamine transmission in DYT1 dystonia: a biochemical and autoradiographical study. Neurology 2002;59:445-448.
185.
Balcioglu A, Kim MO, Sharma N, Cha JH, Breakefield XO, Standaert DG. Dopamine release is impaired in a mouse model of DYT1 dystonia. J Neurochem 2007;102:783-788.
186.
Zhao Y, Decuypere M, Ledoux MS. Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice. Exp Neurol 2008;210:719-730.
187.
Pisani A, Bernardi G, Ding J, Surmeier DJ. Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 2007;30:545-553.
188.
Pisani A, Martella G, Tscherter A, et al. Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. Neurobiol Dis 2006;24:318-325.
189.
Sciamanna G, Bonsi P, Tassone A, et al. Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia. Neurobiol Dis 2009;34:133-145.
190.
Perlmutter JS, Tempel LW, Black KJ, Parkinson D, Todd RD. MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia. Neurology 1997;49:1432-1438.
191.
Tabbal SD, Mink JW, Antenor JA, Carl JL, Moerlein SM, Perlmutter JS. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine. Neurosci 2006;141:1281-1287.
192.
Ma Y, Hu X, Jinnah HA, Galvan A, Smith Y, Wichmann T. Induction of abnormal movements by MPTP treatment in infant rhesus monkeys. Soc Neurosci Abstr 2010.
193.
Mitchell IJ, Luquin R, Boyce S, et al. Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia. Mov Disord 1990;5:49-54.
194.
Hantraye P, Riche D, Maziere M, Isacson O. A primate model of Huntington's disease: behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon. Exp Neurol 1990;108:91-104.
195.
Gerlach J, Hansen L. Clozapine and D1/D2 antagonism in extrapyramidal functions. BrJPychiatr 1997;17(Suppl.):34-37.
196.
Casey DE. Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys. Psychopharmacol (Berlin) 1992;107:18-22.
197.
Vitek JL, Chockkan V, Zhang JY, et al. Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann Neurol 1999;46:22-35.
198.
Vitek JL. Pathophysiology of dystonia: a neuronal model. Mov Disord 2002;17(Suppl. 3):S49-S62.
199.
Lenz FA, Suarez JI, Metman LV, et al. Pallidal activity during dystonia: somatosensory reorganisation and changes with severity. J Neurol Neurosurg Psychiatry 1998;65:767-770.
200.
Zhuang P, Li Y, Hallett M. Neuronal activity in the basal ganglia and thalamus in patients with dystonia. Clin Neurophysiol 2004;115:2542-2557.
201.
Starr PA, Rau GM, Davis V, et al. Spontaneous pallidal neuronal activity in human dystonia: comparison with Parkinson's disease and normal macaque. J Neurophys 2005;93:3165-3176.
202.
Tang JK, Moro E, Mahant N, et al. Neuronal firing rates and patterns in the globus pallidus internus of patients with cervical dystonia differ from those with Parkinson's disease. J Neurophys 2007;98:720-729.
203.
Hamada I, DeLong MR. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J Neurophysiol 1992;68:1859-1566.
204.
Zhuang P, Hallett M, Zhang X, Li J, Zhang Y, Li Y. Neuronal activity in the globus pallidus internus in patients with tics. J Neurol Neurosurg Psychiatry 2009;80:1075-1081.
205.
Lenz FA, Jaeger CJ, Seike MS, et al. Thalamic single neuron activity in patients with dystonia: dystonia-related activity and somatic sensory reorganization. J Neurophys 1999;82:2372-2392.
206.
Silberstein P, Kuhn AA, Kupsch A, et al. Patterning of globus pallidus local field potentials differs between Parkinson's disease and dystonia. Brain 2003;126:2597-2608.
207.
Chen CC, Kuhn AA, Hoffmann KT, et al. Oscillatory pallidal local field potential activity correlates with involuntary EMG in dystonia. Neurology 2006;66:418-420.
208.
Miocinovic S, de Hemptinne C, Qasim S, Ostrem JL, Starr PA. Patterns of cortical synchronization in isolated dystonia compared with Parkinson disease. JAMA Neurol 2015;72:1244-1251.
209.
Jinnah HA, Hess EJ. A new twist on the anatomy of dystonia: the basal ganglia and the cerebellum? Neurology 2006;67:1740-1741.
210.
Calderon DP, Fremont R, Kraenzlin F, Khodakhah K. The neural substrates of rapid-onset Dystonia-Parkinsonism. Nat Neurosci 2011;14:357-365.
211.
Argyelan M, Carbon M, Niethammer M, et al. Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci 2009;29:9740-9747.
212.
Carbon M, Niethammer M, Peng S, et al. Abnormal striatal and thalamic dopamine neurotransmission: Genotype-related features of dystonia. Neurology 2009;72:2097-2103.
213.
Ulug AM, Vo A, Argyelan M, et al. Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. Proc Natl Acad Sci U S A 2011;108:6638-6643.
214.
Prudente CN, Pardo CA, Xiao J, et al. Neuropathology of cervical dystonia. Exp Neurol 2013;241:95-104.
215.
Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2010;68:165-171.
216.
Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009;65:586-595.
217.
Zahodne LB, Okun MS, Foote KD, et al. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol 2009;256:1321-1329.
218.
Locke MC, Wu SS, Foote KD, et al. Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort. Neurosurgery 2011;68:1233-1237.
219.
Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-2091.
220.
Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology 2012;79:55-65.
221.
Odekerken VJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013;12:37-44.
222.
Collomb-Clerc A, Welter ML. Effects of deep brain stimulation on balance and gait in patients with Parkinson's disease: A systematic neurophysiological review. Neurophysiol Clin 2015;45:371-388.
223.
Williams NR, Foote KD, Okun MS. STN vs. GPi deep brain stimulation: translating the rematch into clinical practice. Mov Disord Clin Pract 2014;1:24-35.
224.
Castrioto A, Moro E. New targets for deep brain stimulation treatment of Parkinson's disease. Expert Rev Neurother 2013;13:1319-1328.
225.
Castrioto A, Lhommee E, Moro E, Krack P. Mood and behavioural effects of subthalamic stimulation in Parkinson's disease. Lancet Neurol 2014;13:287-305.
226.
Mazzone P, Lozano A, Stanzione P, et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 2005;16:1877-1881.
227.
Nosko D, Ferraye MU, Fraix V, et al. Low-frequency versus high-frequency stimulation of the pedunculopontine nucleus area in Parkinson's disease: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2015;86:674-679.
228.
Mazzone P, Insola A, Sposato S, Scarnati E. The deep brain stimulation of the pedunculopontine tegmental nucleus. Neuromodulation 2009;12:191-204.
229.
Stefani A, Lozano AM, Peppe A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007;130:1596-1607.
230.
Mazzone P, Sposato S, Insola A, Dilazzaro V, Scarnati E. Stereotactic surgery of nucleus tegmenti pedunculopontine. Br J Neurosurg 2008;22(Suppl. 1):S33-S40.
231.
Ferraye MU, Debu B, Fraix V, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010;133:205-214.
232.
Khan S, Mooney L, Plaha P, et al. Outcomes from stimulation of the caudal zona incerta and pedunculopontine nucleus in patients with Parkinson's disease. Br J Neurosurg 2011;25:273-280.
233.
Thevathasan W, Coyne TJ, Hyam JA, et al. Pedunculopontine nucleus stimulation improves gait freezing in Parkinson disease. Neurosurgery 2011;69:1248-1253.
234.
Fasano A, Aquino CC, Krauss JK, Honey CR, Bloem BR. Axial disability and deep brain stimulation in patients with Parkinson disease. Nat Rev Neurol 2015;11:98-110.
235.
Moro E, Hamani C, Poon YY, et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 2010;133:215-224.
236.
Mazzone P, Paoloni M, Mangone M, et al. Unilateral deep brain stimulation of the pedunculopontine tegmental nucleus in idiopathic Parkinson's disease: effects on gait initiation and performance. Gait Posture 2014;40:357-362.
237.
Khan S, Javed S, Mooney L, et al. Clinical outcomes from bilateral versus unilateral stimulation of the pedunculopontine nucleus with and without concomitant caudal zona incerta region stimulation in Parkinson's disease. Br J Neurosurg 2012;26:722-725.
238.
Khan S, Gill SS, Mooney L, et al. Combined pedunculopontine-subthalamic stimulation in Parkinson disease. Neurology 2012;78:1090-1095.
239.
Schrader C, Seehaus F, Capelle HH, Windhagen A, Windhagen H, Krauss JK. Effects of pedunculopontine area and pallidal DBS on gait ignition in Parkinson's disease. Brain Stim 2013;6:856-859.
240.
Hamani C, Moro E, Lozano AM. The pedunculopontine nucleus as a target for deep brain stimulation. J Neural Transm 2011;118:1461-1468.
241.
Mazzone P, Sposato S, Insola A, Scarnati E. The clinical effects of deep brain stimulation of the pedunculopontine tegmental nucleus in movement disorders may not be related to the anatomical target, leads location, and setup of electrical stimulation. Neurosurgery 2013;73:894-906.
242.
Fasano A, Lozano AM. Deep brain stimulation for movement disorders: 2015 and beyond. Curr Opin Neurol 2015;28:423-436.
243.
Kupsch A, Benecke R, Muller J, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006;355:1978-1990.
244.
Sako W, Goto S, Shimazu H, et al. Bilateral deep brain stimulation of the globus pallidus internus in tardive dystonia. Mov Disord 2008;23:1929-1931.
245.
Capelle HH, Blahak C, Schrader C, et al. Chronic deep brain stimulation in patients with tardive dystonia without a history of major psychosis. Mov Disord 2010;25:1477-1481.
246.
Chang EF, Schrock LE, Starr PA, Ostrem JL. Long-term benefit sustained after bilateral pallidal deep brain stimulation in patients with refractory tardive dystonia. Stereotact Funct Neurosurg 2010;88:304-310.
247.
Gruber D, Trottenberg T, Kivi A, et al. Long-term effects of pallidal deep brain stimulation in tardive dystonia. Neurology 2009;73:53-58.
248.
Shaikh AG, Mewes K, DeLong MR, et al. Temporal profile of improvement of tardive dystonia after globus pallidus deep brain stimulation. Parkinsonism Relat Disord 2015;21:116-119.
249.
Rughani AI, Lozano AM. Surgical treatment of myoclonus dystonia syndrome. Mov Disord 2013;28:282-287.
250.
Rocha H, Linhares P, Chamadoira C, Rosas MJ, Vaz R. Early deep brain stimulation in patients with myoclonus-dystonia syndrome. J Clin Neurosci 2016 Jan 22 [Epub ahead of print].
251.
Kurtis MM, San Luciano M, Yu Q, et al. Clinical and neurophysiological improvement of SGCE myoclonus-dystonia with GPi deep brain stimulation. Clin Neurol Neurosurg 2010;112:149-152.
252.
Gruber D, Kuhn AA, Schoenecker T, et al. Pallidal and thalamic deep brain stimulation in myoclonus-dystonia. Mov Disord 2010;25:1733-1743.
253.
Beukers RJ, Contarino MF, Speelman JD, Schuurman PR, Booij J, Tijssen MA. Deep brain stimulation of the pallidum is effective and might stabilize striatal D(2) receptor binding in myoclonus-dystonia. Front Neurol 2012;3:22.
254.
Welter ML, Grabli D, Vidailhet M. Deep brain stimulation for hyperkinetics disorders: dystonia, tardive dyskinesia, and tics. Curr Opin Neurol 2010;23:420-425.
255.
Fox MD, Alterman RL. Brain Stimulation for Torsion Dystonia. JAMA Neurol 2015;72:713-719.
256.
Pastor-Gomez J, Hernando-Requejo V, Luengo-Dos Santos A, Pedrosa-Sanchez M, Sola RG. [Treatment of a case of generalised dystonia using subthalamic stimulation]. Rev Neurol 2003;37:529-531.
257.
Sun B, Chen S, Zhan S, Le W, Krahl SE. Subthalamic nucleus stimulation for primary dystonia and tardive dystonia. Acta Neurochir Suppl 2007;97:207-214.
258.
Benabid AL, Koudsie A, Benazzouz A, et al. Deep brain stimulation for Parkinson's disease. Adv Neurol 2001;86:405-412.
259.
Lyons KE, Pahwa R. Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson disease. J Neurosurg 2006;104:502-505.
260.
Chou KL, Hurtig HI, Jaggi JL, Baltuch GH. Bilateral subthalamic nucleus deep brain stimulation in a patient with cervical dystonia and essential tremor. Mov Disord 2005;20:377-380.
261.
Ostrem JL, Racine CA, Glass GA, et al. Subthalamic nucleus deep brain stimulation in primary cervical dystonia. Neurology 2011;76:870-878.
262.
Kleiner-Fisman G, Liang GS, Moberg PJ, et al. Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life. J Neurosurg 2007;107:29-36.
263.
Fukaya C, Katayama Y, Kano T, et al. Thalamic deep brain stimulation for writer's cramp. J Neurosurg 2007;107:977-982.
264.
Cho CB, Park HK, Lee KJ, Rha HK. Thalamic deep brain stimulation for writer's cramp. J Korean Neurosurg Soc 2009;46:52-55.
265.
Asahi T, Koh M, Kashiwazaki D, Kuroda S. Stereotactic neurosurgery for writer's cramp: report of two cases with an overview of the literature. Stereotact Funct Neurosurg 2014;92:405-411.
266.
Agnesi F, Connolly AT, Baker KB, Vitek JL, Johnson MD. Deep brain stimulation imposes complex informational lesions. PLoS One 2013;8:e74462.
267.
Temperli P, Ghika J, Villemure JG, Burkhard PR, Bogousslavsky J, Vingerhoets FJ. How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology 2003;60:78-81.
268.
Ruge D, Cif L, Limousin P, et al. Longterm deep brain stimulation withdrawal: clinical stability despite electrophysiological instability. J Neurol Sci 2014;342:197-199.
269.
Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95.
270.
Limousin P, Pollak P, Benazzouz A, et al. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord 1995;10:672-674.
271.
Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005;128:2240-2249.
272.
Dostrovsky JO, Levy R, Wu JP, Hutchison WD, Tasker RR, Lozano AM. Microstimulation-induced inhibition of neuronal firing in human globus pallidus. J Neurophys 2000;84:570-574.
273.
Filali M, Hutchison WD, Palter VN, Lozano AM, Dostrovsky JO. Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus. Exp Brain Res 2004;156:274-281.
274.
Welter ML, Houeto JL, Bonnet AM, et al. Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients. Arch Neurol 2004;61:89-96.
275.
Meissner W, Leblois A, Hansel D, et al. Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain 2005;128:2372-2382.
276.
McIntyre CC, Savasta M, Walter BL, Vitek JL. How does deep brain stimulation work? Present understanding and future questions. Journal of Clinical Neurophysiology 2004;21:40-50.
277.
Kringelbach ML, Jenkinson N, Owen SL, Aziz TZ. Translational principles of deep brain stimulation. Nat Rev Neurosci 2007;8:623-635.
278.
Lee KH, Chang SY, Roberts DW, Kim U. Neurotransmitter release from high-frequency stimulation of the subthalamic nucleus. J Neurosurg 2004;101:511-517.
279.
Chiken S, Nambu A. High-frequency pallidal stimulation disrupts information flow through the pallidum by GABAergic inhibition. J Neurosci 2013;33:2268-2280.
280.
Dostrovsky JO, Lozano AM. Mechanisms of deep brain stimulation. Mov Disord 2002;17 Suppl 3:S63-S68.
281.
Ranck JB. Which elements are excited in electrical stimulation of mammalian central nervous system: A review. Brain Res 1975;98:417-440.
282.
Vitek JL. Mechanisms of deep brain stimulation: excitation or inhibition. Mov Disord 2002;17(Suppl. 3):S69-S72.
283.
Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 2003;23:1916-1923.
284.
Vitek JL, Zhang J, Hashimoto T, Russo GS, Baker KB. External pallidal stimulation improves parkinsonian motor signs and modulates neuronal activity throughout the basal ganglia thalamic network. Exp Neurol 2012;233:581-586.
285.
Grill WM, Snyder AN, Miocinovic S. Deep brain stimulation creates an informational lesion of the stimulated nucleus. Neuroreport 2004;15:1137-1140.
286.
Nambu A, Tokuno H, Hamada I, et al. Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey. J Neurophys 2000;84:289-300.
287.
Zimnik AJ, Nora GJ, Desmurget M, Turner RS. Movement-related discharge in the macaque globus pallidus during high-frequency stimulation of the subthalamic nucleus. J Neurosci 2015;35:3978-3989.
288.
Fukuda M, Ghilardi MF, Carbon M, et al. Pallidal stimulation for parkinsonism: improved brain activation during sequence learning. Ann Neurol 2002;52:144-152.
289.
van Wouwe NC, Ridderinkhof KR, van den Wildenberg WP, et al. Deep brain stimulation of the subthalamic nucleus improves reward-based decision-learning in Parkinson's disease. Front Hum Neurosci 2011;5:30.
290.
Wilkinson L, Beigi M, Lagnado DA, Jahanshahi M. Deep brain stimulation of the subthalamic nucleus selectively improves learning of weakly associated cue combinations during probabilistic classification learning in Parkinson's disease. Neuropsychology 2011;25:286-294.
291.
Mure H, Tang CC, Argyelan M, et al. Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation. J Neurosci 2012;32:2804-2813.
292.
Wilson CJ, Beverlin B, 2nd, Netoff T. Chaotic desynchronization as the therapeutic mechanism of deep brain stimulation. Front Syst Neurosci 2011;5:50.
293.
Moran A, Stein E, Tischler H, Bar-Gad I. Decoupling neuronal oscillations during subthalamic nucleus stimulation in the parkinsonian primate. Neurobiol Dis 2012;45:583-590.
294.
McConnell GC, So RQ, Hilliard JD, Lopomo P, Grill WM. Effective deep brain stimulation suppresses low-frequency network oscillations in the basal ganglia by regularizing neural firing patterns. J Neurosci 2012;32:15657-15668.
295.
Xu WD, Russo GS, Hashimoto T, Zhang JY, Vitek JL. Subthalamic nucleus stimulation modulates thalamic neuronal activity. J Neurosci 2008;28:11916-11924.
296.
Johnson MD, Vitek JL, McIntyre CC. Pallidal stimulation that improves parkinsonian motor symptoms also modulates neuronal firing patterns in primary motor cortex in the MPTP-treated monkey. Exp Neurol 2009;219:359-362.
297.
McCairn KW, Turner RS. Pallidal stimulation suppresses pathological dysrhythmia in the parkinsonian motor cortex. J Neurophysiol 2015;113:2537-2548.
298.
Devergnas A, Wichmann T. Cortical potentials evoked by deep brain stimulation in the subthalamic area. Front Syst Neurosci 2011;5:30.
299.
Li S, Arbuthnott GW, Jutras MJ, Goldberg JA, Jaeger D. Resonant antidromic cortical circuit activation as a consequence of high-frequency subthalamic deep-brain stimulation. J Neurophys 2007;98:3525-3537.
300.
Hanajima R, Ashby P, Lozano AM, Lang AE, Chen R. Single pulse stimulation of the human subthalamic nucleus facilitates the motor cortex at short intervals. J Neurophys 2004;92:1937-1943.
301.
Kuriakose R, Saha U, Castillo G, et al. The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease. Cereb Cortex 2010;20:1926-1936.
302.
Gradinaru V, Mogri M, Thompson KR, Henderson JM, Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009;324:354-359.
303.
Ashby P, Paradiso G, Saint-Cyr JA, Chen R, Lang AE, Lozano AM. Potentials recorded at the scalp by stimulation near the human subthalamic nucleus. Clin Neurophysiol 2001;112:431-437.
304.
MacKinnon CD, Webb RM, Silberstein P, et al. Stimulation through electrodes implanted near the subthalamic nucleus activates projections to motor areas of cerebral cortex in patients with Parkinson's disease. Eur J Neurosci 2005;21:1394-1402.
305.
Eusebio A, Pogosyan A, Wang S, et al. Resonance in subthalamo-cortical circuits in Parkinson's disease. Brain 2009;132:2139-2150.
306.
Sutton AC, O'Connor KA, Pilitsis JG, Shin DS. Stimulation of the subthalamic nucleus engages the cerebellum for motor function in parkinsonian rats. Brain Struct Funct 2015;220:3595-3609.
307.
Bronte-Stewart H, Barberini C, Koop MM, Hill BC, Henderson JM, Wingeier B. The STN beta-band profile in Parkinson's disease is stationary and shows prolonged attenuation after deep brain stimulation. Exp Neurol 2009;215:20-28.
308.
Eusebio A, Thevathasan W, Doyle Gaynor L, et al. Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients. J Neurol Neurosurg Psychiatry 2011;82:569-573.
309.
Eusebio A, Cagnan H, Brown P. Does suppression of oscillatory synchronisation mediate some of the therapeutic effects of DBS in patients with Parkinson's disease? Front Integr Neurosci 2012;6:47.
310.
de Hemptinne C, Swann NC, Ostrem JL, et al. Therapeutic deep brain stimulation reduces cortical phase-amplitude coupling in Parkinson's disease. Nat Neurosci 2015;18:779-786.
311.
McCairn KW, Turner RS. Deep brain stimulation of the globus pallidus internus in the parkinsonian primate: local entrainment and suppression of low-frequency oscillations. J Neurophys 2009;101:1941-1960.
312.
Spieles-Engemann AL, Steece-Collier K, Behbehani MM, et al. Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortex. Journal of Parkinson's disease 2011;1:123-136.
313.
Spieles-Engemann AL, Collier TJ, Sortwell CE. A functionally relevant and long-term model of deep brain stimulation of the rat subthalamic nucleus: advantages and considerations. Eur J Neurosci 2010;32:1092-1099.
314.
Spieles-Engemann AL, Behbehani MM, Collier TJ, et al. Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss. Neurobiol Dis 2010;39:105-115.
315.
Wallace BA, Ashkan K, Heise CE, et al. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain 2007;130:2129-2145.
316.
Temel Y, Visser-Vandewalle V, Kaplan S, et al. Protection of nigral cell death by bilateral subthalamic nucleus stimulation. Brain Res 2006;1120:100-105.
317.
Vedam-Mai V, Gardner B, Okun MS, et al. Increased precursor cell proliferation after deep brain stimulation for Parkinson's disease: a human study. PLoS One 2014;9:e88770.
318.
Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994;117:877-897.
319.
Desmurget M, Turner RS. Testing basal ganglia motor functions through reversible inactivations in the posterior internal globus pallidus. J Neurophys 2008;99:1057-1076.
320.
Desmurget M, Turner RS. Motor sequences and the basal ganglia: kinematics, not habits. J Neurosci 2010;30:7685-7690.
321.
Parent A. Comparative neurobiology of the basal ganglia. New York: John Wiley & Sons 1986.
322.
Raz A, Vaadia E, Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 2000;20:8559-8571.
323.
Raz A, Frechter-Mazar V, Feingold A, Abeles M, Vaadia E, Bergman H. Activity of pallidal and striatal tonically active neurons is correlated in mptp-treated monkeys but not in normal monkeys. J Neurosci 2001;21:RC128.
324.
Goldberg JA, Boraud T, Maraton S, Haber SN, Vaadia E, Bergman H. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. J Neurosci 2002;22:4639-4653.
325.
Goldberg JA, Rokni U, Boraud T, Vaadia E, Bergman H. Spike synchronization in the cortex/basal-ganglia networks of Parkinsonian primates reflects global dynamics of the local field potentials. J Neurosci 2004;24:6003-6010.
326.
Heimer G, Rivlin M, Israel Z, Bergman H. Synchronizing activity of basal ganglia and pathophysiology of Parkinson's disease. J Neural Transm Suppl 2006;70:17-20.
327.
Heimer G, Bar-Gad I, Goldberg JA, Bergman H. Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism. J Neurosci 2002;22:7850-7855.
328.
Stein E, Bar-Gad I. beta oscillations in the cortico-basal ganglia loop during parkinsonism. Exp Neurol 2013;245:52-59.
329.
Brocker DT, Swan BD, Turner DA, et al. Improved efficacy of temporally non-regular deep brain stimulation in Parkinson's disease. Exp Neurol 2013;239:60-67.
330.
Brocker DT, Grill WM. Principles of electrical stimulation of neural tissue. Handb Clin Neurol 2013;116:3-18.
331.
Birdno MJ, Kuncel AM, Dorval AD, Turner DA, Gross RE, Grill WM. Stimulus features underlying reduced tremor suppression with temporally patterned deep brain stimulation. J Neurophysiol 2012;107:364-383.
332.
Popovych OV, Tass PA. Control of abnormal synchronization in neurological disorders. Frontiers in neurology 2014;5:268.
333.
Adamchic I, Hauptmann C, Barnikol UB, et al. Coordinated reset neuromodulation for Parkinson's disease: Proof-of-concept study. Mov Disord 2014;29:1679-1684.
334.
Tass PA, Qin L, Hauptmann C, et al. Coordinated reset has sustained aftereffects in Parkinsonian monkeys. Ann Neurol 2012;72:816-820.
335.
Rosin B, Slovik M, Mitelman R, et al. Closed-loop deep brain stimulation is superior in ameliorating parkinsonism. Neuron 2011;72:370-384.
336.
Little S, Pogosyan A, Neal S, et al. Adaptive deep brain stimulation in advanced Parkinson disease. Ann Neurol 2013;74:449-457.
337.
Pollo C, Kaelin-Lang A, Oertel MF, et al. Directional deep brain stimulation: an intraoperative double-blind pilot study. Brain 2014;137:2015-2026.
338.
Keane M, Deyo S, Abosch A, Bajwa JA, Johnson MD. Improved spatial targeting with directionally segmented deep brain stimulation leads for treating essential tremor. J Neural Eng 2012;9:046005.
339.
Wichmann T. Pathophysiologic basis of movement disorders. In: Niranjan A, Lunsford LD, Richardson M (eds). Controversies in movement disorders. Progress in neurological surgery. Basel (Switzerland): S. Karger AG; 2016 (in press).
Metadaten
Titel
Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality?
verfasst von
Thomas Wichmann
Mahlon R. DeLong
Publikationsdatum
01.04.2016
Verlag
Springer US
Erschienen in
Neurotherapeutics / Ausgabe 2/2016
Print ISSN: 1933-7213
Elektronische ISSN: 1878-7479
DOI
https://doi.org/10.1007/s13311-016-0426-6

Weitere Artikel der Ausgabe 2/2016

Neurotherapeutics 2/2016 Zur Ausgabe

Review

Reorganization of Intact Descending Motor Circuits to Replace Lost Connections After Injury

Review

Targeting Lumbar Spinal Neural Circuitry by Epidural Stimulation to Restore Motor Function After Spinal Cord Injury

Review

Selective Manipulation of Neural Circuits

Review

Leveraging Optogenetic-Based Neurovascular Circuit Characterization for Repair

Original Article

Beneficial Effect of Erythropoietin Short Peptide on Acute Traumatic Brain Injury

Original Article

Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise